GlaxoSmithKline Pakistan. NC Maintains Consistent Market Performance in 2023

Karachi, GlaxoSmithKline Pakistan. NC (GLAXO), a significant entity in the pharmaceutical industry since 1953, maintained consistent market performance in 2023. The company’s stock traded at a high rate of Rs. 83.70 and a low rate of Rs. 84.16. With a paid-up capital of Rs. 3,184.67 million, GlaxoSmithKline Pakistan reported an EPS of Rs. 68 for the year. No distributions were announced for 2022 or 2023.

Check Also

Junaid Chaudhry Announces Establishment of Fisheries, Aquaculture Centre in Karachi

Karachi: Minister for Maritime Affairs Muhammad Junaid Anwar Chaudhry has announced the establishment of a fisheries and aquaculture research centre at the Korangi Fish Harbour Authority in Karachi. According to Radio Pakistan, the Minister stated ...